The aim of this paper is to propose a framework for quantifying the burden of foodrelated ill health and then to use that framework to come to some preliminary conclusions about the burden. For example I suggest that food-related ill health is responsible for about 10% of morbidity and mortality in the UK: a figure which is similar to that due to smoking. In addition I estimate that food-related ill health costs the National Health Service £4 billion. This compares with £2 billion on car and other accidents.
Introduction
When devising food or health policy, policy makers make implicit assumptions about the burden of food-related ill health. If they think it is large (and unfairly distributed) then policy will be directed towards reducing the burden (and its distribution). If they think it is small then policy will be directed towards achieving other objectives. I suggest that implicit assumptions about the burden of food-related ill health should be made more explicit. And that if we think the burden of food-related ill health is large (or small) then we ought to be able to say how large (or small) it is and how much larger (or smaller) it is than other burdens.
I accept that there are a number of problems in measuring the burden of ill health related to food and then comparing that with the burden related to other causes. Comparing the problem of the burden of ill health with other problems that foodpolicy is designed, or might be supposed, to address is even more problematic because of difficulties in finding ways of measuring the burden that permits comparison with those other problems. Here I start to outline how this can be done and generate some preliminary conclusions. However a more systematic study would generate even more useful and surprising results.
I also accept that an understanding of the relative size of the burdens and problems that food and health policies are designed to address is not the only information needed when setting priorities for food and health policy. What is also needed is information about the avoidablility of those burdens/problems. Therefore in statements about the burden of ill-health related to food we need to distinguish between the attributable burden and the avoidable burden (see Figure 1 and also below). The attributable burden is that which is causally related to the factor in question but the avoidable burden is that part of the attributable burden which could be avoided. An understanding of the size of the avoidable burden will come from combining the results of studies of the effectiveness of interventions with information about the extent of the attributable burden. How to do this is beyond the scope of this paper but should be the subject of future work. .
Measuring the burden of ill health
The burden of ill health can be measured in many different ways: the three most common being death, suffering and money. Measuring the burden in terms of death and suffering is important when you need to compare the burden of ill health related to different aspects of the food supply or its consumption (e.g. when comparing the burden of ill health related to low fruit and vegetable consumption with the burden related to food poisoning) or when you need to compare the burden of ill-health related to food with that related to other causes e.g. smoking.
Death and suffering as measures of the burden cannot really be used to compare the problem of food-related ill health to other problems that food policy is designed to address. Suppose we want to compare the benefits to health of a particular agricultural policy with its benefits to farmers' incomes, international trade, the environment, etc. We need a common measure of benefit. Money is often the measure used. Indeed it is difficult to think of any other possible currency.
Death (mortality)
At first sight mortality would seem to be the simplest way of measuring the burden of food-related ill health. Death for most people is an unequivocally bad thing (burdensome). Nevertheless some deaths are worse than others. Deaths at 50 are generally considered worse than deaths at 80. Deaths at 5 are sometimes considered worse than deaths at 0. So mortality can be measured in different ways depending on how you value deaths at different ages. Years of life lost in early death is a common measure of mortality but how you calculate it depends on the relative value you put on life at different ages and what you mean by early. For example if you define early as pre-80, deaths after 80 won't count.
Suffering (or more technically morbidity, disability, poor quality of life or low health status)
Unlike death -which is all or none -suffering is graded: you can suffer a lot or a little. Furthermore it comes in many different forms: pain, loss of mobility, days off work (!), days in hospital etc. Various measures have been devised most of which incorporate a number of these aspects of suffering 1 . Most of these measures use a score on a scale and sometimes these scores can be converted into an amount. For example a score of 100 using the EuroQuol questionnaire would indicate perfect health and 0 would be the worst.
Some of these methods have been adapted for, amongst other things, measuring the burden of ill health through conversion to quality-adjusted life years (QUALYs) 2 . or more recently disability-adjusted life years (DALYs) 3 . Note that there are lots of different ways of calculating QUALYs and DALYs. DALYs are now usually calculated in the way devised by Christopher Murray and Alan Lopez for the World Bank and the World Health Organisation. Table 1 shows that measuring the burden in terms of mortality: in this cases years of life lost through early death (YLLs) gives you very different results from measuring the burden in terms of morbidity: in this cases years of life lost through (living with) disability (YLDs). Table 1 shows for example that in established market economies such as the UK, the diet-related diseases cardiovascular disease (CVD), diabetes and cancer together constitute the overwhelming majority -59% -of years of life lost in early death suggesting to health policy makers that these diseases should be the priority when it comes to devising health programmes. And indeed CVD and cancer, if not diabetes, have been priorities of national health policy in the UK but without the recognition that diseases are particularly diet-related.
But if you don't care about death and are more concerned about suffering then you'd concentrate on diseases other than CVD and cancer -such as neuropsychiatric disorders. CVD, diabetes and cancer only contribute 13% of years of life in disability where as neuropsychiatric disorders contribute 47%.
Death + Suffering
One way of avoiding having to choose between mortality and morbidity when estimating the burden of ill health is to treat them both with equal importance e.g. to add YLLs to YLDs to get a single measure -a disability-adjusted life year lost or DALY (and indeed this is how the Murray and Lopez suggest DALYs should be calculated).
Combining YLLs with YLDs to get DALYs suggests that 36% of the burden of ill health, is due to CVD, diabetes and cancer: now more than say neuropsychiatric disorders at 25%. But note that since DALYs are the sum of years of life lost in early death and years of life lost in disability most of the DALYs due to the diet related disease are from years of life lost in early death rather in disability. It might seem that measuring the burden in terms of mortality and morbidity should be quite objective but actually it turns out that it is quite subjective because 'values' are hugely important when doing the calculations. This 'intrusion' of values into measuring the burden of ill health -even in terms of mortality -is one of the reasons why there are regular media controversies over which disease is the biggest burden. For instance the recent contention that lung disease is Britains biggest killer depends not only how you define lung disease (note that lung disease doesn't appear in Table  1 ) but also depends on how you define killer.
Since any measure of the burden of ill-health which encompasses both mortality and morbidity will tend to hide its underlying values (e.g. whether death is considered more serious than suffering) then it might seem tempting to continue to measure the burden with a variety of measures. But this makes the task of comparing burdens due to different causes well nigh impossible. The DALY seems to be the most useful single measure of the burden of ill health currently available.
Measuring the burden in DALYs suggests that food related diseases -particularly CVD and cancer are important causes of DALYs lost. The burden due to the most important food-related diseases are shown in Table 2 . The table shows that food born diseases -such as salmonella poisoning -constitute a relatively minor burden compared with diet-related diseases: about 0.2% of DALYs lost are due to food-born diseases (mainly diarrhoeal diseases) compared with about 38% from diet-related diseases (all other diseases highlighted in bold in Table 2 ). 
Money
Measuring the burden of ill health in £ is even more problematic than measuring it in terms of mortality or morbidity. Nevertheless the notion that it is in fact possible underlies a whole academic discipline -health economics.
Health charities are fond of making statements such as 'disease x kills costs UK society £z' as if the statement is a burden of disease statement. And indeed I do think the burden of disease can and should be measured in £, but note that even if death and suffering from disease x were to be reduced the cost of disease x to UK society might increase.
This is because neither death nor suffering cost very much. Funerals cost a little as does the alleviation of suffering but it is the attempt to postpone death and prevent suffering which is responsible for the major costs. Both the prevention and treatment of diseases cost money -in particular the wages of health workers, the purchase of drugs, etc. -though the health services spends at least 100 times more on treatment than it does on prevention 4 .
The current cost to the health service of preventing and treating diseases is the simplest way of measuring the burden of ill health in monetary terms. These costs are known as direct costs. But some health economists are happy to put a financial value to non-health service costs e.g. to employers in sickness pay, to unpaid carers for time spent in caring, to patients for lost earnings, etc. These costs are known as indirect costs. Both the direct and indirect costs of different diseases are fairly time consuming to calculate so calculations have not been made for all food-related diseases and when they have been, they have not been calculated in a standard way making comparisons between the numbers generated almost impossible.
To complicate matters there are many possible ways of measuring both direct and indirect costs. The two ways of measuring health service costs are the 'top-down' and the 'bottom-up' approach. The top-down approach estimates costs by aggregating national data on hospital admissions, general practice consultations, prescriptions, etc. to derive an overall total cost. The bottom-up approach uses information on disease and treatment probabilities from small-scale follow-up and other studies to derive overall costs.
The bottom-up approach seems to lead to estimates which are substantially higher than when using the top-down approach.
Take for example two estimates of the cost of diabetes. The charity Diabetes UK, using bottom up methods, estimates the cost of diabetes to the NHS in the UK to be £5.2 billion 5 , while the Centre for Health Economics in Oxford, using top down methods estimate the cost of Type 1 diabetes to be £0.23 billion 6 and Type 2 diabetes to be £1.2 billion 7 making a total of £1.4 billion (and see Table 2 ). Why are diabetes UK's estimates higher than those of the Centre for Health Economics in Oxford?
There would seem to be two explanations. A bottom up approach has the danger that the final amount arrived at is highly susceptible to the initial assumptions. Diabetes UK's estimate is derived from an estimate of the proportion of NHS costs which can be attributed to diabetes (9%) in Glamorgan and multiplying this estimate by the total NHS budget (their estimate of this is £58 billion). But conversely a top-down approach -such as that of the Centre for Health Economics in Oxford -has the danger that it can miss some (even many) items of expenditure. This is particularly the case when the top down approach also seeks to measure the incremental cost of the disease rather than the total cost of the disease. Table 3 shows the results of a review of some of the literature describing top-down cost of disease analyses carried out in the UK. The review was not a systematic review and although systematic methods of accumulating data from cost-of-illness studies are being explored 8 these have not been used very often and there would seem to be no systematic review of all cost-of-illness studies carried out in the UK.
If the direct costs to the NHS of the various diseases listed in Table 3 are added up they come to £12.3 billion pounds compared with total NHS budget of nearly £50 billion for 1999. Clearly either some diseases are missing from Table 1 and/or estimates of costs are too low and/or the costs are incremental.
An alternative (neither top down or bottom up) way of measuring the relative costs to the health service of different diseases is to start with the budget for the health service and apportion costs appropriately. The best example of this type of study was published by the NHS Executive in 1996 9 and described results for the financial year 1992/1993. This study sought to attribute costs to different ICD (International Classification of Disease) chapters rather than individual diseases -so making it difficult to carry out the sort of comparison of the financial burden of food-related diseases that is possible with DALYs. Furthermore the study is now 10 years out of date. If however we assume that there has been little change in the proportion of health care costs attributable to different diseases since 1992/1993 the NHS Executive study provides some indication of the health care costs of food-related diseases and this can be extrapolated to 2001/2002 (Table 4) . Table 4 suggests that at around 28% of NHS costs can be attributed to readily identifiable food-related diseases (highlighted in bold) amounting to about £13 billion in 2001/2002. Table 4 also suggests that CVD and cancer are responsible for most of that £13 billion
Comparing the percentages in Table 4 showing the burden of food-related diseases in direct costs in £ and Table 3 showing the burden in DALYs bears out what we have noted already that ill-health measured in £ may bear only some relationship to illhealth measured in mortality and morbidity. Cancer and diabetes are both a major cause of lost DALYs and a major cost to the health service but dental caries, whilst it is a major cost to the health service is not a major cause of lost DALYs. The budget for general dental services will be 3.6% of the total budget in 2001/2002 9 (and see Table 4 ) while Table 3 suggests that dental caries is only responsible for 0.4% of lost DALYs.
Attributing ill-health to food-related causes
Of course not all of the burden of food-related diseases are directly related to food. All diseases have multiple causes. CVD -to take just one example -is caused by poor diets, smoking, physical activity, stress, etc. Only a proportion of the burden is food-related.
Furthermore, in assessing the relationship it has to be remember that some of the burdens of ill health are overlapping and should, not for that reason, be double counted. Figure 2 illustrates this. The burden of ill health due to cancer clearly does not overlap with the burden due to CVD (or very little) but the burden of diabetes -since diabetes is both a disease in its own right and a risk factor for CVD -does overlap with the burden .of CVD but not cancer. The burden due to diabetes overlaps with that of obesity because obesity is a major cause of diabetes. Obesity, in turn, is partly due to poor diets but also partly to physical inactivity and so forth.
That is another reason why the cost of disease estimates in Table 3 add up to less than expected. Similarly: a recent cost of disease analysis from the National Audit Office found that obesity cost £0.5 billion in direct costs and £2.1 billion in indirect costs. These costs are consistent with similar costs presented in Table 3 but some will already have been accounted for through the effects of obesity on coronary heart disease, stroke and type 2 diabetes.
It is variously claimed that about one third of the mortality and morbidity due to CVD 11 and one third of the mortality and morbidity due to cancer 12 13 are related to poor diets. The estimate for CVD does not seem to have been based on any calculations, the estimate for cancer were originally calculated long before much of the evidence linking diets with cancer became available.
Nor do those making or repeating such estimates seem to be clear about whether they mean attributability or avoidability as illustrated in Figure 1 . Clearly even if everyone adopted a perfect diet today, CVD would not fall by a third tomorrow so over what time span are they talking about when they suggest one third of CVD is related to poor diets? Similarly those making the claims do not seem to have been specific about what they meant by poor diets. To estimate attributability and avoidability in relation to diets then a comparison has to be made with an ideal diet (attibutability) or at least a better diet (avoidability). What are, or were, those (counterfactual) diets?
The World Health Organisation Comparative Risk Assessment Project is currently carrying out an analysis of the burden of disease that can be attributed/avoided in relation to a range of risk factors. Two of the risk factors they are considering are low fruit and vegetable consumption and overweight/obesity but the results of their analysis are not yet available.
Meanwhile Table 5 puts together the results of two studies which conclude that a similar proportion -about 10% -of DALYS lost in developed economies are related to poor diets. Although these studies are vague about the distinction between attributability and avoidability they are the best available calculations of the proportion of the burden of mortality and morbidity due to poor diets that we have at the present time.. 15 .
Actually these results accord quite neatly (coincidentally?) with the cruder estimates that about a third of CVD and cancer can be attributed to poor diets: because CVD and cancer together constitute about 30% of DALYs lost (Table 1 ) and one third of 30% is 10%.
Note that 10% is about the proportion of DALYs lost due to smoking yet health policy, in as much as it has been concerned with the prevention of disease, has traditionally accorded much more attention to smoking than to poor diets.
Assessing the proportion of the burden of ill-health measured in financial terms that is food-related is not simple because -as we have seen there is only some relationship between the burden measured in £ or in DALYs. However a conservative estimate would be that one third of the costs of the health service of the readily identifiable food related diseases shown in Table 4 (£13 billion) might be attributable to foodrelated causes (if not avoidable through alleviating those causes) i.e. £4 billion.
The £4 billion due to food-related ill health is twice the cost of accidents including car (and indeed rail) accidents shown in Table 4 . The £4 billion might also cautiously be compared with economic costs of food-born diseases recently calculated by Jules Pretty and his colleagues. They argue that BSE and nvCJD have recently had direct and indirect costs of £0.6 billion p.a. and that bacterial and viral outbreaks in food have cost £0.2 billion p.a. 16 . Note that although these costs are substantial they are relatively small compared with £4 billion.
